These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22147810)

  • 61. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study.
    Meyer JH; Kapur S; Eisfeld B; Brown GM; Houle S; DaSilva J; Wilson AA; Rafi-Tari S; Mayberg HS; Kennedy SH
    Am J Psychiatry; 2001 Jan; 158(1):78-85. PubMed ID: 11136637
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys.
    Gould RW; Gage HD; Banks ML; Blaylock BL; Czoty PW; Nader MA
    Neuropharmacology; 2011; 61(1-2):245-51. PubMed ID: 21521647
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study.
    Daumann J; Fimm B; Willmes K; Thron A; Gouzoulis-Mayfrank E
    Brain Res Cogn Brain Res; 2003 May; 16(3):479-87. PubMed ID: 12706227
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preliminary evidence of motor impairment among polysubstance 3,4-methylenedioxymethamphetamine users with intact neuropsychological functioning.
    Bousman CA; Cherner M; Emory KT; Barron D; Grebenstein P; Atkinson JH; Heaton RK; Grant I;
    J Int Neuropsychol Soc; 2010 Nov; 16(6):1047-55. PubMed ID: 20735886
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
    Morgan MJ; Impallomeni LC; Pirona A; Rogers RD
    Neuropsychopharmacology; 2006 Jul; 31(7):1562-73. PubMed ID: 16292322
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans.
    Erritzoe D; Holst K; Frokjaer VG; Licht CL; Kalbitzer J; Nielsen FA; Svarer C; Madsen J; Knudsen G
    J Neurosci; 2010 Mar; 30(9):3391-7. PubMed ID: 20203198
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity.
    Bull EJ; Hutson PH; Fone KC
    Neuropharmacology; 2004 Feb; 46(2):202-10. PubMed ID: 14680758
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL; Hamilton C; Kennedy DO; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').
    Ricaurte GA; McCann UD; Szabo Z; Scheffel U
    Toxicol Lett; 2000 Mar; 112-113():143-6. PubMed ID: 10720723
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls.
    Quednow BB; Kühn KU; Hoenig K; Maier W; Wagner M
    Neuropsychopharmacology; 2004 May; 29(5):982-90. PubMed ID: 14970829
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report.
    Reneman L; Majoie CB; Schmand B; van den Brink W; den Heeten GJ
    Biol Psychiatry; 2001 Oct; 50(7):550-4. PubMed ID: 11600108
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').
    McCann UD; Slate SO; Ricaurte GA
    Drug Saf; 1996 Aug; 15(2):107-15. PubMed ID: 8884162
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.
    McCann UD; Eligulashvili V; Mertl M; Murphy DL; Ricaurte GA
    Psychopharmacology (Berl); 1999 Nov; 147(1):56-65. PubMed ID: 10591869
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.
    Gerra G; Zaimovic A; Ferri M; Zambelli U; Timpano M; Neri E; Marzocchi GF; Delsignore R; Brambilla F
    Biol Psychiatry; 2000 Jan; 47(2):127-36. PubMed ID: 10664829
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
    Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug users.
    Cowan RL; Bolo NR; Dietrich M; Haga E; Lukas SE; Renshaw PF
    Psychiatry Res; 2007 Aug; 155(3):179-88. PubMed ID: 17574394
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 5-HT2 receptor distribution shown by [18F] setoperone PET in high-functioning autistic adults.
    Beversdorf DQ; Nordgren RE; Bonab AA; Fischman AJ; Weise SB; Dougherty DD; Felopulos GJ; Zhou FC; Bauman ML
    J Neuropsychiatry Clin Neurosci; 2012; 24(2):191-7. PubMed ID: 22772667
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Repeated adolescent MDMA ("Ecstasy") exposure in rats increases behavioral and neuroendocrine responses to a 5-HT2A/2C agonist.
    Biezonski DK; Courtemanche AB; Hong SB; Piper BJ; Meyer JS
    Brain Res; 2009 Feb; 1252():87-93. PubMed ID: 19059385
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use.
    Hanson KL; Luciana M
    Psychol Med; 2004 Feb; 34(2):229-46. PubMed ID: 14982129
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity.
    Li IH; Ma KH; Kao TJ; Lin YY; Weng SJ; Yen TY; Chen LC; Huang YS
    Neurotoxicology; 2016 Jan; 52():114-26. PubMed ID: 26610922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.